Leading Blog

MARCH 12, 2024

Given that the global biotechnology market was valued at USD 1.55 Some fail for a host of strategic or operational shortcomings addressed in any decent business school course. Assemble diverse teams with complementary skills and a shared vision. Models are developed, scrutinized, and refined.

Tips 340

Tips Due Diligence Biotechnology Entrepreneur 340

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. economy, expands America's global trade, and attracts foreign companies to base operations in the U.S.

Competitive Advantage 12

Competitive Advantage Globalization Development Intellectual Capital 12

Harvard Business Review

FEBRUARY 3, 2015

Your network’s strategic advantage and, therefore, the extent to which it helps you step up to leadership, depends on three qualities: Breadth: Strong relationships with a diverse range of contacts. Breadth: How Diverse Is Your Network? Dynamism: A dynamic set of extended ties that evolves as you evolve.

How To 8

How To Diversity Letter Learning-by-Doing 8

Harvard Business Review

MARCH 30, 2017

Looking at the executive teams we work with as consultants and those we teach in the classroom, increased diversity of gender, ethnicity, and age is apparent. Of course, there is a ways to go, but progress has been made. Since there is so much focus on the importance of diversity in problem solving, we were intrigued by these results.

Diversity 8

Diversity Team Biotechnology Execution 8

Harvard Business Review

MARCH 17, 2014

As the sector grows through this period of creative destruction, models that don’t work will die out, models that survive will attract copycats, operating costs will go down, and winners will rise to the top. Second, in addition to time, the sector needs a framework to measure success, one that makes sense of the sector’s inherent diversity.

Development 8

Development Microfinance Biotechnology Exit Strategy 8

Harvard Business Review

JULY 22, 2015

.” Hanguk was a large, fast-growing company with diversified interests spanning electronics, biotechnology, shipping, construction, and chemicals. Of course it was natural for a boss to have mixed feelings about seeing a valued employee move on, but David was more than Mark’s manager: He was his mentor. ” Mark said.

Case Study 8

Case Study Career Biotechnology Course 8